DIA Biosimilars 2013

Quintiles

Premier Research names Sean Russell marketing VP

Monday, February 13, 2012 03:53 PM

Premier Research Group has appointed Sean Russell vice president, marketing.

More... »

Cenduit: Now with Patient Reminders

Quintiles launches innovative Center of Excellence in China

Wednesday, January 18, 2012 04:09 PM

Quintiles is opening a business process outsourcing (BPO) and project management center of excellence in Dalian, China, a major city with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets.

More... »

CRF Health – eCOA Forum

Susan Stansfield named executive VP, clinical development at Premier Research

Friday, January 13, 2012 12:03 PM

Premier Research Group has named Susan C. Stansfield, Ph.D., its new executive vice president of clinical development.

More... »

Quintiles forms Digital Patient Unit

Tuesday, January 3, 2012 01:14 PM

Quintiles has formed a Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage patients.

More... »

Intarcia, Quintiles form strategic partnership

Thursday, December 22, 2011 12:38 PM
Intarcia Therapeutics and Quintiles have signed definitive agreements whereby Quintiles will become a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650.

More... »

Icon boosts its presence in Asia with acquisition of Chinese CRO BeijingWits Medical Consulting

Monday, December 19, 2011 10:13 AM

Now that many mid-tier CROs have been acquired by either equity investment firms or other CROs and the trend has slowed, a new form of consolidation is emerging. Robust CROs are rounding out their offerings with small but strategic acquisitions to make them bigger, stronger and more complete. The ultimate goal: to continue winning lucrative strategic outsourcing agreements from sponsors.  

More... »

Quintiles launches Kun Tuo

Tuesday, December 13, 2011 09:51 AM

Quintiles has launched Kun Tuo, a local contract research organization built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

More... »

Survey: Sponsor’s choice of central lab affects investigator’s satisfaction with trial experience

Monday, December 12, 2011 09:04 AM

The choice of a central lab can greatly affect a principal investigator’s satisfaction level while conducting a clinical trial. 

More... »

Quintiles, Prodia partner to provide central lab testing in Indonesia

Thursday, December 1, 2011 12:31 PM

Quintiles has reported an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia. This will allow Quintiles’ biopharmaceutical customers to conduct clinical research in Indonesia and help establish the potential benefits of new medicines in the Indonesian population while contributing to global programs.

More... »

Quintiles expands with lab in South Africa

Thursday, December 1, 2011 11:48 AM

Quintiles has opened a new, expanded central lab in Centurion, South Africa, further adding to its world-leading network of fully harmonized, College of American Pathologists (CAP)-accredited central labs.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs